Assessment of Patients with Psoriatic Arthritis: A Review of Currently Available Measures

Arthritis and Rheumatism

Volumn 50, Issue 1, 2004, Pages 24-35

  Gladman, Dafna D ^a   Helliwell, Philip ^b   Mease, Philip J ^c   Nash, Peter ^d   Ritchlin, Christopher ^e   Taylor, William ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE;

ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; DISABILITY; DISEASE ACTIVITY; ENTHESITIS; FATIGUE; HUMAN; INFLAMMATION; JOINT DESTRUCTION; JOINT RADIOGRAPHY; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PSYCHOMETRY; REVIEW; RHEUMATOID ARTHRITIS; SPINE MOBILITY; SPONDYLITIS; TENDINITIS; VALIDATION PROCESS;

ARTHRITIS, PSORIATIC; DISABILITY EVALUATION; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 0346458589     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11417     Document Type: Review

References (87)

1. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
2. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe H. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992;19:1115-9.
3. Gladman DD. Psoriatic arthritis. Rheum Dis Clin North Am 1998;24:829-44.
4. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. JAMA 1949;140:659-62.
5. Ritchie DM, Boyle JA, McKinnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968;37:393-406.
6. Gladman DD. Psoriatic arthritis. Baillière's Clinical Rheumatology 1995;9:319-29.
7. Cooperating Clinics Committee of The American Rheumatism Association. A seven-day variability study of 488 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965;8:302-34.
8. Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:62-4.
9. Montgomery DC. Design and analysis of experiments. 3rd ed. New York: John Wiley & Sons; 1991.
10. Gladman DD, Cook RJ, Schentag C, Feletar M, Inman R, Hitchon C, et al. The clinical assessment of patients with psoriatic arthritis: results of a validation study of the Spondyloarthritis Research Consortium of Canada [abstract]. Arthritis Rheum 2003;48 Suppl 9:S168.
11. Thompson PW, Hart LE, Goldsmith CH, Spector TD, Bell MJ, Ramsden MF. Comparison of four articular indices for use in clinical trials in RA: patient, order and observer variation. J Rheumatol 1991;18:661-5.
12. Fuchs HA, Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994;37:470-5.
13. Gladman DD, Farewell VT, Kopciuk K, Cook RJ. HLA antigens and progression in psoriatic arthritis. J Rheumatol 1998;25:730-3.
14. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 1993;16:1-7.
15. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis: clinical and laboratory analysis of 220 patients. QJM 1987;62:127-41.
16. Pile KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO. Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 1991; 30:29-34.
17. Schober P. The lumbar vertebral column and the backache. MMW 1937;84:336-8.
18. Macrae IF, Wright V. Measurement of back movement. Ann Rheum Dis 1969;28:584-9.
19. Viitanen JV, Kokko ML, Heikkila S, Kautiainen H. Assessment of thoracolumbar rotation in ankylosing spondylitis: a simple tape method. Clin Rheumatol 1999;18:152-7.
20. Miller MH, Lee P, Smythe HA, Goldsmith CH. Measurements of spinal mobility in the sagittal plane: new skin contraction technique compared with established methods. J Rheumatol 1984;11: 507-11.
21. Brockbank JB, Schimmer K, Schentag C, Hyrich KL, Gladman DD. Spinal disease assessment in psoriatic arthritis [abstract]. J Rheumatol 2001;28 Suppl 63:62.
22. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis: the Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
23. Portek I, Pearcy MJ, Reader GP, Mowat AG. Correlation between radiographic and clinical measurement of lumbar spine movement. Br J Rheumatol 1983;22:197-205.
24. Calin A, Nakache J-P, Gueguen A, Zeidler H, Mielants H, Dougados M. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. J Rheumatol 1999;26:975-9.
25. Helliwell PS, Abbott C, Chamberlain MA. A randomized trial of three different physiotherapy regimes in ankylosing spondylitis. Physiotherapy 1996;82:85-90.
26. Olivieri I, Barozzi L, Favaro L, Pierro A, de Matteis M, Borghi C, et al. Dactylitis in patients with seronegative spondylarthropathy. Arthritis Rheum 1996;39:1524-8.
27. Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999;26:1746-51.
28. Brockbank J, Stein M, Schentag C, Gladman D. Characteristics of dactylitis in psoriatic arthritis [abstract]. J Rheumatol 2001;28: 1416.
29. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2004-12.
30. Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987;46: 197-202.
31. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R, van der Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-32.
32. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157:238-44.
33. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385-90.
34. Antoni C, Kavanaugh A, Kirkham B, Burmester G, Weisman M, Keystone E, et al. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [abstract]. Arthritis Rheum 2002;46 Suppl 9:S381.
35. Mease P, Kivitz A, Burch F, Siegel E, Cohen S, Burge D. Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract]. Arthritis Rheum 2001;44 Suppl 9:S90.
36. Kaltwasser P, Nash P, Gladman D, Mease P. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis: results from the TOPAS study [abstract]. Arthritis Rheum 2002;46:3416.
37. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001;357:1842-7.
38. Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998;41:1103-10.
39. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-4.
40. Fries JF, Spitz P, Kraines RG, Holman HH. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:127-45.
41. Daltroy LH, Lasron MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990;17:946-50.
42. Blackmore M, Gladman DD, Husted J, Long J, Farewell VT. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22: 886-93.
43. Husted J, Gladman DD, Farewell V, Long J. Modified HAQ in psoriatic arthritis. Clin Exp Rheumatol 1995;13:439-44.
44. Wanke LA, Gottlieb AB, Mease PJ, Kivitz AJ, Cohen SB, Burge DJ, et al. Etanercept (Enbrel) improves health-related quality of life in patients with psoriatic arthritis [abstract]. Arthritis Rheum 2002;46 Suppl 9:S76.
45. Van Tubergen A, Landewe R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H, et al. Assessment of disability with the World Health Organization Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:140-5.
46. Husted J, Gladman DD, Farewell VT, Long J. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic arthritis. J Rheumatol 1996;23:1015-9.
47. Husted J, Gladman DD, Long JA, Farewell VT. Relationship of the Arthritis Impact Measurements Scales (AIMS) to changes in articular status and functional performance in patients with psoriatic arthritis. J Rheumatol 1996;23:1932-7.
48. Husted J, Gladman DD, Long JA, Farewell VT, Cook R. Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7.
49. Husted JA, Gladman DD, Cook RJ, Farewell VJ. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol 1998;25:2146-55.
50. Schrader P, Mooser G, Peter RU, Puhl W. Preliminary results in the therapy of psoriatic arthritis with mycophenolate mofetil. Z Rheumatol 2002;61:545-50.
51. Helliwell PS, Marzo-Ortega H, Tennant A. Comparison of a disease-specific and a generic instrument for measuring health-related quality of life in ankylosing spondylitis [concise communication]. Arthritis Rheum 2002;45:3098.
52. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 1999;38:878-82.
53. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
54. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
55. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 2002;83 Suppl 2:S10-7.
56. Smets EMA, Garsen B, Bonke B, de Haes JCJM. The multidimensional fatigue inventory: psychometric qualities of an instrument to assess fatigue. J Psychosomatic Res 1995;39:315-25.
57. Van Tubergen A, Coenen J, Landewe R, Spoorenberg A, Chorus A, Boonen A, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Care Res 2002;47:1-8.
58. Schentag CT, Beaton M, Rahman P, Husted J, Gladman DD. Prevalence and correlates of fatigue in psoriatic arthritis [abstract]. Arthritis Rheum 2000;43 Suppl 9:S105.
59. Schentag CT, Gladman DD. Changes in fatigue in psoriatic arthritis: disease activity or fibromyalgia [abstract]. Arthritis Rheum 2002;46 Suppl 9:S424.
60. Daunt AON, Cox MJ, Robertson JC, Cawley MJD. Indices of disease activity in psoriatic arthritis. J Roy Soc Med 1987;80: 556-8.
61. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2013-20.
62. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
63. Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 1998;41: 1564-70.
64. Gladman DD, Farewell VT. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheumatol 1999;26:2409-13.
65. Van Gestel AM, Prevoo MLL, van 't Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34-40.
66. Van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, et al, for the American College of Rheumatology European League of Associations for Rheumatology. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol 1999;26:705-11.
67. Van der Heijde D, van der Linden S, Dougados M, Bellamy N, Russell AS, Edmonds J. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol 1999;26:1003-5.
68. Sharp JT. An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis. J Rheumatol 2000;27:254-60.
69. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 1971;14:706-20.
70. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999;26:743-5.
71. Larsen A. A radiographic method for grading the severity of rheumatoid arthritis. Medical thesis, University of Helsinki, 1974.
72. Larsen A. How to apply the Larsen score in evaluating radiographs of rheumatoid arthritis in longterm studies. J Rheumatol 1999;22: 1974-5.
73. Rau R, Heborn G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1999;22:1976-82.
74. Pincus T, Callahan L, Fuchs H, Larsen A, Kaye J. Quantitative analysis of hand radiographs in rheumatoid arthritis: time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol 1999; 22:1983-9.
75. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998;37:760-5.
76. Rahman P, Gladman DD, Zhou Y, Cook RJ. The use of sulfasalazine in psoriatic arthritis: a clinic experience. J Rheumatol 1998; 25:1957-61.
77. Ory P, Sharp JT, Salonen D, Rubenstein J, Mease PJ, Kivitz AJ, et al. Etanercept (Enbrel) inhibits radiographic progression in patients with psoriatic arthritis [abstract]. Arthritis Rheum 2002;46 Suppl 9:S196.
78. Wassenberg S, Fischer O, Kahle V, Herborn G, Rau R. A method to score radiographic change in psoriatic arthritis. Z Rheumatol 2001;60:156-66.
79. Taouli B, Guermazi A, Sack KE, Genant HK. Imaging of the hand and wrist in RA. Ann Rheum Dis 2002;61:867-9.
80. Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, et al. Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002;61:895-904.
81. Bliddal H, Qvistgaard E, Terslev L, Savnik A, Holm CC, Danneskiold-Samsǿe B. Injection of etanercept into arthritis joints: dose-response and efficacy [abstract]. Arthritis Rheum 2002;46 Suppl 9:S518.
82. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998;41: 694-700.
83. Frediani B, Falsetti P, Storri L, Allegri A, Bisogno S, Baldi F, et al. Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 2002;21:203-6.
84. Alcade M, Cruz M, Bordoy C, Gonzalez L, Acebes C, Sanchez-Pernaute O, et al. Assessment of entheseal injury in ankylosing spondylitis by ultrasound [abstract]. Arthritis Rheum 2002;46 Suppl 9:S427.
85. Kamel M, Mansour R, Eid H, Fernandez I. Ultrasound detection of patellar enthesitis: a comparison with MRI [abstract]. Arthritis Rheum 2002;46 Suppl 9:S104.
86. Klasser A, Springer P, Frauscher F, Schirmer M. Comparison between magnetic resonance imaging, unenhanced and contrast enhanced ultrasound in the diagnosis of active sacroiliitis [abstract]. Arthritis Rheum 2002;46 Suppl 9:S426.
87. McGonagle D, Stockwin L, Isaacs J, Emery P. An enthesitis based model for the pathogenesis of spondylarthropathy: additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 2001;28:2155-9.